Optimizing launch insights strategy
Pharma launch plans often overlook a critical driver of success: a formal insights strategy.
Optimizing Patient Outcomes: Medical Affairs’ Strategic Role in the Enterprise Commercialization Process (ECP)
Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
Bridging the gap: How medical affairs is reshaping the future of clinical and commercial success
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
Unveiling the Role of Medical Affairs in the Benelux
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
Executive Vision: Emerging Ideas in Medical Affairs’ Role in Adapting Industry to Personalized Medicine
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
Medical Affairs Mastery: Shaping the Future of MedTech with MAPS
Join the MAPS Med Tech FAWG as they discuss “Medical Affairs Mastery: Shaping the Future of MedTech with MAPS”!
Executive Vision: How Medical Affairs Will Help the Biopharmaceutical and MedTech industries Adapt to Meet the Needs of a Changing Society
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
The Mission, Value, and Roles of Medical Affairs in MedTech
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
Medical Affairs in Rare Disease and Gene Therapy – Why a different approach?
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
Execution to Strategy: Accelerating the Transformation of Medical Affairs Vision 2030
In this webinar, we will discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization.